Treatment Decision-Making in Metastatic Prostate Cancer: Perceptions of Locus of Control Among Patient, Caregiver, and Physician Triads

被引:11
|
作者
Schumacher, Frank A. [1 ]
Helenowski, Irene B. [1 ]
Oswald, Laura B. [2 ]
Gonzalez, Brian D. [2 ]
Benning, James T. [1 ]
Morgans, Alicia K. [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, 1835 W Thomas St,Apt 2F, Chicago, IL 60622 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Program Hlth Outcomes & Behav, Tampa, FL USA
来源
PATIENT PREFERENCE AND ADHERENCE | 2022年 / 16卷
关键词
prostate cancer; decision making; shared decision making; treatment decisions; cancer; INVOLVEMENT; PREFERENCES; INFORMATION; ROLES; WOMEN;
D O I
10.2147/PPA.S334827
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Multiple treatments for metastatic prostate cancer have similar efficacy, leaving patients with complicated treatment choices. Shared decision-making can facilitate difficult treatment decisions, but the extent to which this is used for metastatic prostate cancer is unknown. We assessed patient, caregiver, and physician perceptions of decision locus of control (shared decision-making vs physician- or patient-directed decisions) and the degree of agreement between groups. Methods: Triads of patients, caregivers, and physicians completed surveys of decisionmaking practices after a clinic visit in which a decision occurred. To evaluate the degree of agreement for decision locus of control, we used the quadratic-weighted kappa coefficient (Kappa). We used relative frequencies to evaluate which knowledge learned and treatment factors were most strongly endorsed by patients as informing and influencing their treatment decision-making, respectively. Results: Fifty triads participated, with median patient age of 72 years. A majority of patients, caregivers, and physicians reported shared decision-making (66%, 56%, and 52%, respectively). Patients and physicians demonstrated minimal agreement about decision locus of control (44%, Kappa=0.35 [SD = 0.52]), but caregiver reports were not statistically significantly associated with physician and patient reports (38%, Kappa=0.23, [SD = 0.28]), p=0.055; 44%, Kappa=0.34 [SD = 1.98], p=0.14). Treatment efficacy was the most common patientreported factor influencing treatment decisions (44%). Conclusion: This study characterized metastatic prostate cancer patients', caregivers', and physicians' experiences and communication preferences for treatment decision-making. Patients and physicians had greater agreement in decision locus of control compared with caregivers, yet patient-physician agreement was minimal. Metastatic prostate cancer patients report being influenced by information about treatment efficacy and clear next steps, and a desire for patient-friendly language and an invitation to be as involved in decision making at their preferred level. Emphasizing these may increase agreement in decision locus of control between all participants in the decision-making process.
引用
收藏
页码:235 / 244
页数:10
相关论文
共 50 条
  • [1] Treatment decision-making among patients with metastatic prostate cancer: Impact of decision locus of control on functional outcomes and decision satisfaction
    Schumacher, Frank A. A.
    Helenowski, Irene B. B.
    Sun, Zequn
    Oswald, Laura B. B.
    Gonzalez, Brian D. D.
    Moses, Kelvin A. A.
    Benning, James T. T.
    Morgans, Alicia K. K.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (01) : 201 - 206
  • [2] Treatment decision-making among patients with metastatic prostate cancer: Impact of decision locus of control on functional outcomes and decision satisfaction
    Frank A. Schumacher
    Irene B. Helenowski
    Zequn Sun
    Laura B. Oswald
    Brian D. Gonzalez
    Kelvin A. Moses
    James T. Benning
    Alicia K. Morgans
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 201 - 206
  • [3] Caregiver Perceptions of Clinical Decision-Making for the Treatment of Children
    Allen, Brian
    Varela, Alberto
    COMMUNITY MENTAL HEALTH JOURNAL, 2015, 51 (07) : 828 - 832
  • [4] Caregiver Perceptions of Clinical Decision-Making for the Treatment of Children
    Brian Allen
    Alberto Varela
    Community Mental Health Journal, 2015, 51 : 828 - 832
  • [5] Collaboration with patient caregiver, patient advocate and physician to highlight the barriers, benefits and solutions for shared decision-making (SDM) in prostate cancer
    Wang, Yuan
    Merchant, Pooja
    Carl, Gunther
    Manarite, Jan
    Boegemann, Martin
    Dayaram, Yaswant
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 : S12 - S13
  • [7] Patient participation in the decision-making process of localised prostate cancer treatment-the decision-making role of the patient
    Wang, Luke
    Ranasinghe, Weranja
    BJU INTERNATIONAL, 2016, 118 : 13 - 13
  • [8] TREATMENT DECISION-MAKING AMONG PATIENTS WITH ADVANCED PROSTATE CANCER
    Jones, Randy
    ONCOLOGY NURSING FORUM, 2018, 45 (02)
  • [9] Patient assertiveness and physician decision-making among older breast cancer patients
    Krupat, E
    Irish, JT
    Kasten, LE
    Freund, KM
    Burns, RB
    Moskowitz, MA
    McKinlay, JB
    SOCIAL SCIENCE & MEDICINE, 1999, 49 (04) : 449 - 457
  • [10] PATIENT PERCEPTIONS OF DECISION MAKING AND A WEB-BASED DECISION-MAKING AID FOR EARLY STAGE PROSTATE CANCER
    Fleisher, Linda
    Kandadai, Venk
    ANNALS OF BEHAVIORAL MEDICINE, 2010, 39 : 130 - 130